”a phase 3 company priced like a phase 2 company”.
that’s because it is a phase 2 company.
this asset had negligible data in the old phase 2 it’s almost pointless. So the part 1 of this current trial first 70 patients that takes it to the mid Mar futility analysis is effectively the phase 2 that was never done for this asset.
- Forums
- ASX - By Stock
- DXB
- Ann: Quarterly Appendix 4C and Activities Report
Ann: Quarterly Appendix 4C and Activities Report, page-37
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
56.8¢ |
Change
0.043(8.10%) |
Mkt cap ! $310.8M |
Open | High | Low | Value | Volume |
51.5¢ | 57.3¢ | 50.5¢ | $1.962M | 3.606M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 35648 | 56.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
57.0¢ | 21542 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 20519 | 0.565 |
6 | 107709 | 0.560 |
5 | 154185 | 0.555 |
12 | 836260 | 0.550 |
6 | 46544 | 0.545 |
Price($) | Vol. | No. |
---|---|---|
0.570 | 21455 | 6 |
0.575 | 95753 | 7 |
0.580 | 257763 | 7 |
0.585 | 108923 | 7 |
0.590 | 79466 | 7 |
Last trade - 15.29pm 19/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |